Mineralocorticoid receptor agonists to treat LVSD?
examples: eplerenone, spironolactone
mechanism: promote Na+ excretion and K+ reabsorption. act on distal tubule (as opposed to proximal tubule in loop diuretics).
difference is that mineralocorticoid receptor agonists keep potassium, whereas loop diuretics lose it in the process of excreting Na+.
have effects outside the kidney - reduce hypertrophy and fibrosis
gynaecomastia (painful excess breast tissue growth)
electrolyte abnormalities (high K+)